Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): Focus on Long-Term MRD Results

Michael J Keating, Koichi Takahashi + Show 30 more

Open Access

https://doi.org/10.1182/blood-2021-154454

Copy DOI

Journal: Blood	Publication Date: Nov 5, 2021
Citations: 1

Abstract

Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): Focus on Long-Term MRD Results

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author